批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2021/05/14 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/04/24 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/12/18 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/12/14 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/07/22 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/12/04 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/05/02 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/02/18 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/08/17 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/03/11 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/02/05 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/12/18 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/08/04 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/01/15 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/06/25 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/03/05 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/11/01 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/11/01 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/06/13 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1994/07/27 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1994/06/13 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1980/12/12 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:TOBRAMYCIN 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:0.3% 治疗等效代码:AT
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050541 |
001 |
NDA |
TOBREX |
TOBRAMYCIN |
SOLUTION/DROPS;OPHTHALMIC |
0.3% |
Discontinued |
Yes |
No |
AT |
Approved Prior to Jan 1, 1982
|
NOVARTIS |
062535 |
001 |
ANDA |
TOBREX |
TOBRAMYCIN |
SOLUTION/DROPS;OPHTHALMIC |
0.3% |
Prescription |
No |
No |
AT |
1984/12/13
|
SANDOZ |
064052 |
001 |
ANDA |
TOBRAMYCIN |
TOBRAMYCIN |
SOLUTION/DROPS;OPHTHALMIC |
0.3% |
Prescription |
No |
No |
AT |
1993/11/29
|
BAUSCH AND LOMB |
064096 |
001 |
ANDA |
AKTOB |
TOBRAMYCIN |
SOLUTION/DROPS;OPHTHALMIC |
0.3% |
Discontinued |
No |
No |
AT |
1996/01/31
|
EPIC PHARMA LLC |
065026 |
001 |
ANDA |
TOBRAMYCIN |
TOBRAMYCIN |
SOLUTION/DROPS;OPHTHALMIC |
0.3% |
Prescription |
No |
No |
AT |
2001/09/11
|
CHARTWELL RX |
207444 |
001 |
ANDA |
TOBRAMYCIN |
TOBRAMYCIN |
SOLUTION/DROPS;OPHTHALMIC |
0.3% |
Prescription |
No |
Yes |
AT |
2017/06/28
|
SOMERSET THERAPS LLC |
211847 |
001 |
ANDA |
TOBRAMYCIN |
TOBRAMYCIN |
SOLUTION/DROPS;OPHTHALMIC |
0.3% |
Prescription |
No |
No |
AT |
2019/04/19
|
ALEMBIC |
212628 |
001 |
ANDA |
TOBRAMYCIN |
TOBRAMYCIN |
SOLUTION/DROPS;OPHTHALMIC |
0.3% |
Prescription |
No |
No |
AT |
2021/03/09
|
GLAND PHARMA LTD |